Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Early indomethacin reduces early atrial fibrillation recurrence after AF ablation

May 20, 2010

Odanacatib promising in phase II trial in postmenopausal women with low BMD

May 20, 2010

JAK2 inhibitor TG-AZ1 sensitizes lung cancer cells to radiation

May 20, 2010

Myriad's candidate anticancer therapeutics inhibit Nampt

May 20, 2010

Promising preclinical profile of MEK kinase inhibitor TAK-733

May 20, 2010

Menveo protects adults age 56 years and older from meningococcal disease

May 20, 2010

IBAT inhibitor A-3309 improves constipation in double-blind trial

May 20, 2010

Fixed-dose ibuprofen/famotidine combination HZT-501 evaluated in healthy volunteers

May 19, 2010

Promising interim phase I/II data on TNF-alpha kinoid in Crohn's disease

May 19, 2010

Macrolides CSY-3655 and CSY-0073 show promise in mouse models of inflammation

May 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...